Swiss haemovigilance data and implementation of measures for the prevention of transfusion associated acute lung injury (TRALI)

Transfusion Medicine and Hemotherapy

Volumn 35, Issue 2, 2008, Pages 98-101

  Jutzi, Markus ^a,b   Levy, Guy ^a   Taleghani, Behrouz Mansouri ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Swiss Agy for Therapeutic Products   (Switzerland)

Author keywords

Haemovigilance; Prevention; TRALI; Transfusion risk

Indexed keywords

FRESH FROZEN PLASMA;

ADVERSE OUTCOME; ALERTNESS; ARTICLE; BACTERIUM CONTAMINATION; BLOOD DONOR; DATA ANALYSIS; HEMOVIGILANCE; POLICY; PREVENTION AND CONTROL; RISK ASSESSMENT; SWITZERLAND; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY;

EID: 42349111571     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119120     Document Type: Article

References (9)

1. Swissmedic: Hämovigilanz Bericht 2002/2003; www.swissmedic.ch/ files/pdf/Haemovigilance_Jahresbericht_D.pdf.
2. Kleinman S, Caulfield T, Chan P, et al.: Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44:1774-89.
3. Michlig C, Vu D-H, Wasserfallen J-B, Spahn DR, Schneider P, Tissot J-D: Three years of hemovigilance in a general university hospital. Transfus Med 2003;13:63-73.
4. SHOT Annual Report 2006, p. 13; www.shotuk.org/SHOT_report_2006.pdf.
5. Davis A, Mandal R, Johnson M, Makar R, Stowell C, Dzik S: A touch of TRALI. Transfusion 2008:48:541-5.
6. Niederhauser C, Schneider P, Fopp M, Ruefer A, Lévy G: Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Euro Surveill 2005;10:14-6.
7. Bux J, Sachs UJ: The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007;136:788-99.
8. Silliman C: The two-event model of transfusion-related acute lung injury. Crit Care Med 2006;34:S124-31.
9. Senn M, Mansouri Taleghani B: International forum: measures to prevent TRALI. Vox Sang 2007;92:258-277.